Advances in the treatment of dyslipidemia.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26974988.
- Also identified by DOI 10.3949/ccjm.83gr.16001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although current guidelines do not set specific targets for lowering levels of low-density lipoprotein cholesterol (LDL-C), several lines of evidence support the concept that "lower is better." Statin drugs in combination with new agents now make it possible to lower LDL-C to new lows. Determining the risk of cardiovascular disease in apparently healthy adults and how far to extend treatment for primary prevention has critical implications for public health.
Medical subject headings
- Atherosclerosis
- Dyslipidemias
- Hypolipidemic Agents
- Primary Prevention